Helbig G, Bober G, Seweryn M, Wichary R, Tukiendorf A, Sedlak L, et al. OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE. Mediterr J Hematol Infect Dis [Internet]. 2015 Jan. 1 [cited 2024 Nov. 23];7(1):e2015003. Available from: https://www.mjhid.org/mjhid/article/view/2015.003